Malignant Fibrous Histiocytoma Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Nivolumab and BO-112 Before Surgery for the Treatment of Resectable Soft Tissue Sarcoma
Conditions: Leiomyosarcoma; Myxofibrosarcoma; Resectable Dedifferentiated Liposarcoma; Resectable Soft Tissue Sarcoma; Resectable Undifferentiated Pleomorphic Sarcoma; Soft Tissue Fibrosarcoma; Spindle Cell Sarcoma; Stage I Retroperitoneal Sarcoma American Joint Committee on Cancer (AJCC) v8; Stage I Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8; Stage IA Retroperitoneal Sarcoma AJCC v8; Stage IA Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8; Stage IB Retroperitoneal Sarcoma AJCC v8; Stage IB Soft Tissue Sarcoma of the Tru nk and Extremities...
Source: ClinicalTrials.gov - June 9, 2020 Category: Research Source Type: clinical trials

Vismodegib and Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced or Metastatic Sarcoma
Conditions: Adult Alveolar Soft-part Sarcoma; Adult Angiosarcoma; Adult Desmoplastic Small Round Cell Tumor; Adult Epithelioid Hemangioendothelioma; Adult Epithelioid Sarcoma; Adult Extraskeletal Chondrosarcoma; Adult Extraskeletal Osteosarcoma; Adult Fibrosarcoma; Adult Leiomyosarcoma; Adult Liposarcoma; Adult Malignant Fibrous Histiocytoma; Adult Malignant Mesenchymoma; Adult Neurofibrosarcoma; Adult Rhabdomyosarcoma; Adult Synovial Sarcoma; Chondrosarcoma; Clear Cell Sarcoma of the Kidney; Conjunctival Kaposi Sarcoma; Dermatofi...
Source: ClinicalTrials.gov - June 29, 2010 Category: Research Source Type: clinical trials